Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment‐related mortality-Reference-Cited by-同舟云学术

Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment‐related mortality

Published:2020-12-24 Issue:3 Volume:96 Page:282-291
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Maiti Abhishek¹²^ORCID,Qiao Wei³,Sasaki Koji¹^ORCID,Ravandi Farhad¹,Kadia Tapan M.¹^ORCID,Jabbour Elias J.¹^ORCID,Daver Naval G.¹^ORCID,Borthakur Gautam¹^ORCID,Garcia‐Manero Guillermo¹^ORCID,Pierce Sherry A.¹,Montalbano Kathryn S.¹,Pemmaraju Naveen¹^ORCID,Naqvi Kiran¹,Ohanian Maro¹^ORCID,Short Nicholas J.¹^ORCID,Alvarado Yesid¹,Takahashi Koichi¹,Yilmaz Musa¹^ORCID,Jain Nitin¹,Kornblau Steven M.¹,Andreeff Michael¹^ORCID,Bose Prithviraj¹^ORCID,Ferrajoli Alessandra¹,Issa Ghayas C.¹,Masarova Lucia¹,Thompson Philip A.¹,Rausch Caitlin R.⁴^ORCID,Ning Jing⁴,Kantarjian Hagop M.¹^ORCID,DiNardo Courtney D.¹^ORCID,Konopleva Marina Y.¹^ORCID

Affiliation:

1. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas USA

2. Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston Texas USA

3. Department of Biostatistics The University of Texas MD Anderson Cancer Center Houston Texas USA

4. Division of Pharmacy The University of Texas MD Anderson Cancer Center Houston Texas USA

Funder

National Institutes of Health

The National Cancer Institute

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26061

Reference27 articles.

1. Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia

2. Induction therapy for elderly patients with acute myeloid leukemia

3. Acute myeloid leukemia in the elderly: therapeutic options and choice

4. Acute myeloid leukemia in the older adults

5. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of patients with acute myeloid leukemia treated with intensive therapy after failure of venetoclax-inclusive, less-intensive therapy;Leukemia Research;2024-11

2. Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1-mutant AML;Blood Advances;2024-09-24

3. Updates in biology, classification, and management of acute myeloid leukemia with antecedent hematologic disorder and therapy related acute myeloid leukemia;Leukemia Research;2024-09

4. Ven the dose matters: Venetoclax dosing in the frontline treatment of AML;Blood Reviews;2024-08

5. Acute myeloid leukemia (AML) with chromosome 3 inversion: biology, management, and clinical outcome;Leukemia & Lymphoma;2024-07-04